Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: A link between vascular and fibrotic features

Arthritis Research and Therapy

Volumn 16, Issue 1, 2014, Pages

  Cipriani, Paola ^a   di Benedetto, Paola ^a   Ruscitti, Piero ^a   Campese, Antonio Francesco ^b   Liakouli, Vasiliki ^a   Carubbi, Francesco ^a   Pantano, Ilenia ^a   Berardicurt, Onorina ^a   Screpanti, Isabella ^b   Giacomelli, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; ACTIN; COLLAGEN TYPE I, ALPHA 1 CHAIN; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2, HUMAN; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; CELL CULTURE; CELL INTERACTION; CELL SELECTION; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STEM CELL; MIDDLE AGED; MYOFIBROBLAST; OBSERVATIONAL STUDY; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SYSTEMIC SCLEROSIS; YOUNG ADULT; ANGIOGENESIS; CELL COMMUNICATION; DIFFUSE SCLERODERMA; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACTINS; ADULT; BLOTTING, WESTERN; CELL COMMUNICATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE I; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; MYOFIBROBLASTS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCLERODERMA, DIFFUSE; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; YOUNG ADULT;

EID: 84988857126     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-014-0442-z     Document Type: Article

References (44)

1. Varga J, Abraham D: Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest 2007, 117:557-567.
2. LeRoy EC: Systemic sclerosis. A vascular perspective. Rheum Dis Clin North Am 1996, 22:675-694.
3. Loeys BL, Gerber EE, Riegert-Johnson D, Iqbal S, Whiteman P, McConnell V, Chillakuri CR, Macaya D, Coucke PJ, De Paepe A, Judge DP, Wigley F, Davis EC, Mardon HJ, Handford P, Keene DR, Sakai LY, Dietz HC: Mutations in fibrillin-1 cause congenital scleroderma: stiff skin syndrome. Sci Transl Med 2010, 2:23ra20.
4. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L: Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012, 18:1262-1270.
5. Cipriani P, Carubbi F, Liakouli V, Marrelli A, Perricone C, Perricone R, Alesse E, Giacomelli R: Stem cells in autoimmune diseases: implications for pathogenesis and future trends in therapy. Autoimmun Rev 2013, 12:709-716.
6. Hunzelmann N, Brinckmann J: What are the new milestones in the pathogenesis of systemic sclerosis? Ann Rheum Dis 2010, 69:i52-i56.
7. Carmeliet P, Jain RK: Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
8. Gabrielli A, Avvedimento EV, Krieg T: Scleroderma. N Engl J Med 2009, 360:1989-2003.
9. Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C: Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 2003, 17:1835-1840.
10. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA: An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 1989, 86:4544-4548.
11. Hirschi KK, Rohovsky SA, D'Amore PA: PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10 T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998, 141:805-814.
12. Armulik A, Abramsson A, Betsholtz C: Endothelial/ pericyte interactions. Circ Res 2005, 97:512-523.
13. Diaz-Flores L, Gutierrez R, Gonzalez P, Varela H: Inducible perivascular cells contribute to the neochondrogenesis in grafted perichondrium. Anat Rec 1991, 229:1-8.
14. Díaz-Flores L, Gutierrez R, Lopez-Alonso A, Gonzalez R, Varela H: Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin Orthop Relat Res 1992, 275:280-286.
15. Saleh FA, Whyte M, Ashton P, Genever PG: Regulation of mesenchymal stem cell activity by endothelial cells. Stem Cells Dev 2011, 20:391-403.
16. Díaz-Flores L, Gutiérrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martín-Vasallo P, Díaz-Flores L Jr: Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009, 24:909-969.
17. Dulmovits BM, Herman IM: Microvascular remodeling and wound healing: A role for pericytes. Int J Biochem Cell Biol 2012, 44:1800-1812.
18. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010, 176:85-97.
19. Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J: A pericyte origin of spinal cord scar tissue. Science 2011, 333:238-242.
20. Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, Loos T, Kasprzycka M, Sørensen DR, Nilsen HR, Küchler AM, Vatn MH, Haraldsen G: Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol 2010, 177:2804-2815.
21. Sato M, Suzuki S, Senoo H: Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct Funct 2003, 28:105-112.
22. Cai X, Lin Y, Friedrich CC, Neville C, Pomerantseva I, Sundback CA, Zhang Z, Vacanti JP, Hauschka PV, Grottkau BE: Bone marrow derived pluripotent cells are pericytes which contribute to vascularization. Stem Cell Rev 2009, 5:437-445.
23. Bianco P, Riminucci M, Gronthos S, Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
24. Cipriani P, Marrelli A, Di Benedetto P, Liakouli V, Carubbi F, Ruscitti P, Alvaro S, Pantano I, Campese AF, Grazioli P, Screpanti I, Giacomelli R: Sclerodermia mesenchymal stem cells display a differentphenotype from healthy controls; implications for regenerative medicine. Angiogenesis 2013, 16:595-607.
25. Pedersen TO, Blois AL, Xue Y, Xing Z, Sun Y, Finne-Wistrand A, Lorens JB, Fristad I, Leknes KN, Mustafa K: Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation. Stem Cell Res Ther 2014, 5:23.
26. Bergers G, Song S: The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005, 7:452-464.
27. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
28. Cipriani P, Guiducci S, Miniati I, Cinelli M, Urbani S, Marrelli A, Dolo V, Pavan A, Saccardi R, Tyndall A, Giacomelli R, Cerinic MM: Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 2007, 56:1994-2004.
29. Lilly B, Kennard S: Differential gene expression in a coculture model of angiogenesis reveals modulation of select pathways and a role for Notch signaling. Physiol Genomics 2009, 36:69-78.
30. Liu H, Kennard S, Lilly B: NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res 2009, 104:466-475.
31. Lin SL, Chang FC, Schrimpf C, Chen YT, Wu CF, Wu VC, Chiang WC, Kuhnert F, Kuo CJ, Chen YM, Wu KD, Tsai TJ, Duffield JS: Targeting endothelium-pericyte cross talk by inhibiting VEGF receptor signaling attenuates kidney microvascular rarefaction and fibrosis. Am J Pathol 2011, 178:911-923.
32. Jimenez SA: Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol 2013, 2013:1-15.
33. Evensen L, Micklem DR, Blois A, Berge SV, Aarsaether N, Littlewood-Evans A, Wood J, Lorens JB: Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 2009, 4:e5798.
34. Darland DC, Massingham LJ, Smith SR, Piek E, Saint-Geniez M, D'Amore PA: Pericyte production of cell-associated VEGF is differentiation-dependent and is associated with endothelial survival. Dev Biol 2003, 264:275-288.
35. Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA: A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008, 456:809-813.
36. Manetti M, Guiducci S, Romano E, Bellando-Randone S, Lepri G, Bruni C, Conforti ML, Ibba-Manneschi L, Matucci-Cerinic M: Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis. Ann Rheum Dis 2013, 72:1425-1427.
37. Harris S, Craze M, Newton J, Fisher M, Shima DT, Tozer GM, Kanthou C: Do anti-angiogenic VEGF (VEGFxxxb) isoforms exist? A cautionary tale. PLoS One 2012, 7:e35231.
38. Harris S, Craze M, Newton J, Fisher M, Shima DT, Tozer GM, Kanthou C: VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A. Mol Cancer 2010, 31:320.
39. Kisseleva T, Cong M, Paik Y, Scholten D, Jiang C, Benner C: Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci 2012, 109:9448-9453.
40. Gilbane AJ, Denton CP, Holmes AM: Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther 2013, 15:215.
41. Rodriguez A, Friman T, Kowanetz M, van Wieringen T, Gustafsson R, Sundberg C: Phenotypical differences in connective tissue cells emerging from microvascularpericytes in response to overexpression of PDGF-B and TGF-β1 in normal skin in vivo. Am J Pathol 2013, 182:2132-2146.
42. Goumans MJ, Liu Z, ten Dijke P: TGF-b signaling in vascular biology and dysfunction. Cell Res 2009, 19:116-127.
43. Yamakage A, Kikuchi K, Smith EA, LeRoy EC, Trojanowska M: Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts. J Exp Med 1992, 175:1227-1234.
44. Rajkumar C, Sundberg VS, Abraham DJ, Rubin K, Black CM: Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis. Arthritis Rheum 1999, 42:930-941.